ITGAX and neoplasm: In vitro phagocytosis assay with Raji GFPhi cells showed higher engulfment of tumor cells by DCs after NI-1701 treatment (9.5% versus 1.7% CD11c+GFP+ events for hIgG1, Fig. 4a), which was confirmed by analysing double-positive CD11c+GFP+ cells using imaging flow cytometry.